About Joseph Gerardi
Joseph Gerardi is an executive officer at Syncromune.
Joseph Gerardi reports to the SEC as an officer of 1 public company: Angiodynamics (ANGO).
Joseph Gerardi first appears on SEC filings in 2006.
Experience
This experience comes from Joseph Gerardi's profile and from SEC filings. For roles taken from filings, the years are when the filings name Joseph Gerardi in the role, so the role may have started earlier or lasted longer.
SY
Syncromune™ Current
Chief Financial Officer
2020 – Present
FL
Fox Hollow Financial Consulting, LLC Current
Founder & Chief Executive Officer
2015 – Present
Syncromune, Inc.
Executive officer
2022 – 2026 · Fort Lauderdale, FL
Develops investigational immune therapies for people with metastatic solid tumors.
II
ImmunSYS, Inc.
Executive Vice President, Chief Financial Officer, Treasurer, Secretary.
2018 – 2020
AL
Advanced Vascular Resources, LLC
Vice President, Chief Financial Officer
2014 – 2015
PC
Paradigm Spine LLC (Viscogloisi Brothers, LLC held company)
Vice President, Chief Financial Officer
2008 – 2011
AI
Angiodynamics Inc.
Vice President, Special Projects
1992 – 2008 · Public company (ANGO)
MA
Mallinckrodt
Plant Controller
1987 – 1992
FS
FACTRON/Schlumberger
Cost Accountant
1986 – 1992
Key Colleagues at Startups
The people Joseph Gerardi works with at each company, as listed on that company's latest Form D.
Syncromune, Inc. · Form D/A, May 11, 2026
Jeffrey Cleland
Director
Douglas Watson
Lead Independent Director
JM
Joseph Maroon
Director
Stephen Dale
Chief Medical Officer
NS
Norman Schwartz
Director
Charles Link
Executive Chairman & Chief Innovation Officer
Eamonn Hobbs
President & Chief Executive Officer, director
Kerri-Ann Millar
Chief Financial Officer
Agustin Gago
Chief Operating Officer